Bionano Genomics (BNGO) Competitors $3.40 +0.02 (+0.59%) Closing price 04:00 PM EasternExtended Trading$3.42 +0.02 (+0.74%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNGO vs. AATC, DAIO, CLIR, MSAI, PRPO, STAI, ASTC, TLIS, AXDX, and TBIOShould you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Autoscope Technologies (AATC), Data I/O (DAIO), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), Precipio (PRPO), ScanTech AI Systems (STAI), Astrotech (ASTC), Talis Biomedical (TLIS), Accelerate Diagnostics (AXDX), and Telesis Bio (TBIO). These companies are all part of the "measuring and control equipment" industry. Bionano Genomics vs. Its Competitors Autoscope Technologies Data I/O ClearSign Technologies MultiSensor AI Precipio ScanTech AI Systems Astrotech Talis Biomedical Accelerate Diagnostics Telesis Bio Bionano Genomics (NASDAQ:BNGO) and Autoscope Technologies (NASDAQ:AATC) are both small-cap measuring and control equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Does the media prefer BNGO or AATC? In the previous week, Bionano Genomics had 4 more articles in the media than Autoscope Technologies. MarketBeat recorded 4 mentions for Bionano Genomics and 0 mentions for Autoscope Technologies. Bionano Genomics' average media sentiment score of 0.38 beat Autoscope Technologies' score of 0.00 indicating that Bionano Genomics is being referred to more favorably in the media. Company Overall Sentiment Bionano Genomics Neutral Autoscope Technologies Neutral Which has preferable valuation and earnings, BNGO or AATC? Autoscope Technologies has lower revenue, but higher earnings than Bionano Genomics. Bionano Genomics is trading at a lower price-to-earnings ratio than Autoscope Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionano Genomics$28.46M0.40-$112.02M-$138.92-0.02Autoscope Technologies$12.89M3.21$6.62M$0.7310.34 Do analysts recommend BNGO or AATC? Bionano Genomics currently has a consensus price target of $7.00, suggesting a potential upside of 105.88%. Given Bionano Genomics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Bionano Genomics is more favorable than Autoscope Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Autoscope Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders have more ownership in BNGO or AATC? 11.4% of Bionano Genomics shares are held by institutional investors. 0.9% of Bionano Genomics shares are held by company insiders. Comparatively, 21.6% of Autoscope Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is BNGO or AATC more profitable? Autoscope Technologies has a net margin of 37.59% compared to Bionano Genomics' net margin of -294.05%. Autoscope Technologies' return on equity of 27.06% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Bionano Genomics-294.05% -125.75% -71.96% Autoscope Technologies 37.59%27.06%23.97% Which has more risk & volatility, BNGO or AATC? Bionano Genomics has a beta of 2.2, suggesting that its stock price is 120% more volatile than the S&P 500. Comparatively, Autoscope Technologies has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. SummaryBionano Genomics and Autoscope Technologies tied by winning 8 of the 16 factors compared between the two stocks. Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNGO vs. The Competition Export to ExcelMetricBionano GenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.44M$2.93B$5.57B$9.31BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-0.0220.5028.6119.73Price / Sales0.40267.14411.30174.40Price / CashN/A43.1536.0257.96Price / Book0.197.768.235.67Net Income-$112.02M-$55.11M$3.23B$257.79M7 Day Performance1.49%0.96%0.01%0.54%1 Month Performance-3.95%8.45%5.63%8.86%1 Year Performance-91.40%-2.37%26.55%14.22% Bionano Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNGOBionano Genomics1.984 of 5 stars$3.40+0.6%$7.00+105.9%-91.0%$11.44M$28.46M-0.02300AATCAutoscope Technologies1.9144 of 5 stars$7.50flatN/A+19.9%$41.18M$12.89M8.5240DAIOData I/O1.6071 of 5 stars$3.17+0.3%$4.00+26.2%+14.7%$29.29M$21.77M-10.93100Positive NewsCLIRClearSign Technologies2.4536 of 5 stars$0.54flat$2.00+272.4%-36.8%$28.16M$3.60M-4.4810MSAIMultiSensor AI3.7833 of 5 stars$0.66+1.6%$2.50+278.3%-51.0%$22.10M$7.40M0.0035PRPOPrecipio0.9164 of 5 stars$13.98+16.0%N/A+218.9%$21.11M$18.53M-6.7560Positive NewsHigh Trading VolumeSTAIScanTech AI SystemsN/A$0.71-1.5%N/AN/A$18.18M$542.17K0.00N/ANews CoverageASTCAstrotech1.512 of 5 stars$5.64-0.2%N/A-32.9%$9.53M$1.66M-0.6710Gap DownTLISTalis BiomedicalN/A$1.40flatN/A-85.2%$2.55M$300K-0.05260AXDXAccelerate Diagnostics1.1776 of 5 starsN/AN/AN/A$857K$11.70M-0.01220Gap DownHigh Trading VolumeTBIOTelesis BioN/A$0.30flatN/A-99.3%$541K$225.09M-0.01200 Related Companies and Tools Related Companies AATC Alternatives DAIO Alternatives CLIR Alternatives MSAI Alternatives PRPO Alternatives STAI Alternatives ASTC Alternatives TLIS Alternatives AXDX Alternatives TBIO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNGO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
